Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
US veterinary drug compounding firms Wedgewood Pharmacy and Diamondback Drugs have agreed to a merger.
With a decision on Elanco's future due in a week, Animal Pharm editor Joseph Harvey provides a recap of the company's situation and what can be expected over the next seven days.
Dutch animal feed firm Royal De Heus has continued to make acquisitions to ramp up its presence in growing markets.
Animal Pharm is conducting an online poll on the potential future of Elanco, which is pending the decision of Eli Lilly's strategic review.
Zoetis' acquisition of Abaxis has now been cleared under the Hart-Scott-Rodino Antitrust Improvements Act (HSR Act).
US firm Archer Daniels Midland (ADM) has signified its intentions to establish itself as a leading animal nutrition business through two significant transactions.
Merck could be eyeing a move for Elanco, according to one media source.
Alivira Animal Health remains on the acquisition trial, as it aims to fill in the geographic gaps in its sales network.
Chicago-based private equity firm Wind Point Partners is set to acquire Canadian feed additives and pet bedding company Pestell.
US animal nutrition firm BioZyme has acquired a range of feed ingredients through a deal for Cogent Solutions Group (CGS).
Neovia's latest acquisition has seen it take a majority stake in Nigerian premix feed manufacturer Hi Nutrients.
The UK's largest independent provider of analytical laboratory testing services for the land-based industries Cawood Scientific has acquired an Irish poultry serology specialist.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.